Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Endotoxin reduction in protein solutions using octyl β-D-1-thioglucopyranoside wash on chromatography media.

Gadre D, Carlson M, Mullan A, Kabundi I, Pedowitz N, Rieder SA, White N, Yu K, O'Connor E.

J Chromatogr A. 2018 Nov 9;1575:49-58. doi: 10.1016/j.chroma.2018.09.021. Epub 2018 Sep 18.

PMID:
30262393
2.

2017 White Paper on recent issues in bioanalysis: a global perspective on immunogenicity guidelines & biomarker assay performance (Part 3 - LBA: immunogenicity, biomarkers and PK assays).

Gupta S, Richards S, Amaravadi L, Piccoli S, Desilva B, Pillutla R, Stevenson L, Mehta D, Carrasco-Triguero M, Neely R, Partridge M, Staack RF, Zhao X, Gorovits B, Kolaitis G, Sumner G, Stubenrauch KG, Zou L, Amur S, Beaver C, Berger I, Berisha F, Birnboeck H, Bower J, Cho SJ, Cludts I, Cocea L, Donato LD, Fischer S, Fraser S, Garofolo F, Haidar S, Haulenbeek J, Hottenstein C, Hu J, Ishii-Watabe A, Islam R, Jani D, Kadavil J, Kamerud J, Kramer D, Kurki P, MacMannis S, McNally J, Mullan A, Papadimitriou A, Pedras-Vasconcelos J, Ray S, Safavi A, Saito Y, Savoie N, Fjording MS, Scheibner K, Smeraglia J, Song A, Stouffer B, Tampal N, der Strate BV, Verch T, Welink J, Xu Y, Yang TY, Yengi L, Zeng J, Zhang Y, Zhang Y, Zoog S.

Bioanalysis. 2017 Dec;9(24):1967-1996. doi: 10.4155/bio-2017-4974. Epub 2017 Dec 5.

PMID:
29205064
3.

Effects of a beverage rich in (poly)phenols on established and novel risk markers for vascular disease in medically uncomplicated overweight or obese subjects: A four week randomized placebo-controlled trial.

Mullan A, Delles C, Ferrell W, Mullen W, Edwards CA, McColl JH, Roberts SA, Lean ME, Sattar N.

Atherosclerosis. 2016 Mar;246:169-76. doi: 10.1016/j.atherosclerosis.2016.01.004. Epub 2016 Jan 6.

PMID:
26797134
4.

Fatal oxidative haemolysis and methaemoglobinaemia in a patient with alkaptonuria and acute kidney injury.

Mullan A, Cocker D, Taylor G, Millar C, Ranganath L.

Clin Kidney J. 2015 Feb;8(1):109-12. doi: 10.1093/ckj/sfu121. Epub 2014 Nov 17.

5.

Characterization of the inflammatory response to inhaled lipopolysaccharide in mild to moderate chronic obstructive pulmonary disease.

Gupta V, Banyard A, Mullan A, Sriskantharajah S, Southworth T, Singh D.

Br J Clin Pharmacol. 2015 May;79(5):767-76. doi: 10.1111/bcp.12546.

6.

Rapid recovery of membrane cofactor protein (MCP; CD46) associated atypical haemolytic uraemic syndrome with plasma exchange.

Reid VL, Mullan A, Erwig LP.

BMJ Case Rep. 2013 Sep 4;2013. pii: bcr2013200980. doi: 10.1136/bcr-2013-200980.

7.

Epidemiological survey of Clostridium difficile ribotypes in the North East of England during an 18-month period.

Vanek J, Hill K, Collins J, Berrington A, Perry J, Inns T, Gorton R, Magee J, Sails A, Mullan A, Gould FK.

J Hosp Infect. 2012 Jul;81(3):209-12. doi: 10.1016/j.jhin.2012.04.017. Epub 2012 May 24.

PMID:
22633277
8.

A pilot study on the effect of short-term consumption of a polyphenol rich drink on biomarkers of coronary artery disease defined by urinary proteomics.

Mullen W, Gonzalez J, Siwy J, Franke J, Sattar N, Mullan A, Roberts S, Delles C, Mischak H, Albalat A.

J Agric Food Chem. 2011 Dec 28;59(24):12850-7. doi: 10.1021/jf203369r. Epub 2011 Nov 28.

PMID:
22070129
9.

Aseptic loosening of total hip arthroplasty: infection always should be ruled out.

Parvizi J, Suh DH, Jafari SM, Mullan A, Purtill JJ.

Clin Orthop Relat Res. 2011 May;469(5):1401-5. doi: 10.1007/s11999-011-1822-1. Epub 2011 Mar 2.

10.

Bioavailability of multiple components following acute ingestion of a polyphenol-rich juice drink.

Borges G, Mullen W, Mullan A, Lean ME, Roberts SA, Crozier A.

Mol Nutr Food Res. 2010 Jul;54 Suppl 2:S268-77. doi: 10.1002/mnfr.200900611.

PMID:
20521274
11.

More knocks to the oxidation hypothesis for vascular disease?

Mullan A, Sattar N.

Clin Sci (Lond). 2009 Jan;116(1):41-3. doi: 10.1042/CS20080486. Review.

PMID:
18844607
12.

Service improvement.

Janes G, Mullan A.

Nurs Manag (Harrow). 2007 Oct;14(6):22-5. Review. No abstract available.

PMID:
17966209
13.

Obesity: which drug and when?

Lean M, Mullan A.

Int J Clin Pract. 2007 Sep;61(9):1555-60. Review.

PMID:
17686095
14.

Polyphosphate accumulation by Pseudomonas putida CA-3 and other medium-chain-length polyhydroxyalkanoate-accumulating bacteria under aerobic growth conditions.

Tobin KM, McGrath JW, Mullan A, Quinn JP, O'Connor KE.

Appl Environ Microbiol. 2007 Feb;73(4):1383-7. Epub 2006 Dec 8.

15.

Effect of reduced pH on inorganic polyphosphate accumulation by Burkholderia cepacia complex isolates.

Moriarty TF, Mullan A, McGrath JW, Quinn JP, Elborn JS, Tunney MM.

Lett Appl Microbiol. 2006 Jun;42(6):617-23.

16.

Pilot-scale evaluation of the application of low pH-inducible polyphosphate accumulation to the biological removal of phosphate from wastewaters.

Mullan A, McGrath JW, Adamson T, Irwin S, Quinn JP.

Environ Sci Technol. 2006 Jan 1;40(1):296-301.

PMID:
16433364
17.

Repeated antenatal corticosteroids: effects on cerebral palsy and childhood behavior.

French NP, Hagan R, Evans SF, Mullan A, Newnham JP.

Am J Obstet Gynecol. 2004 Mar;190(3):588-95.

PMID:
15041985
18.

Should two senior cancer-nursing posts be integrated as one leadership function?

McEnvoy M, Mullan A.

Int J Palliat Nurs. 2003 Sep;9(9):404-10; discussion 410. Review.

PMID:
14593277
20.

Enhanced phosphate uptake and polyphosphate accumulation in Burkholderia cepacia grown under low pH conditions.

Mullan A, Quinn JP, McGrath JW.

Microb Ecol. 2002 Jul;44(1):69-77. Epub 2002 Apr 4.

PMID:
12187377

Supplemental Content

Loading ...
Support Center